Cost-effectiveness of Anticipatory and Preventive multidisciplinary Team Care for complex patients Evidence from a randomized controlled trial

被引:0
|
作者
Gray, David [2 ]
Armstrong, Catherine Deri [2 ,4 ]
Dahrouge, Simone [1 ]
Hogg, William [3 ]
Zhang, Wei [5 ]
机构
[1] Univ Ottawa, Dept Family Med, Elisabeth Bruyere Res Inst, CT Lamont Primary Hlth Care Res Ctr, Ottawa, ON K1N 5C8, Canada
[2] Univ Ottawa, Dept Econ, Ottawa, ON K1N 6N5, Canada
[3] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada
[4] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada
[5] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada
关键词
COGNITIVE-BEHAVIORAL THERAPY;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE To evaluate the cost-effectiveness of Anticipatory and Preventive Team Care (APTCare). DESIGN Analysis of data drawn from a randomized controlled trial. SETTING A family health network in a rural area near Ottawa, Ont. PARTICIPANTS Patients 50 years of age or older at risk of experiencing adverse health outcomes. Analysis of cost-effectiveness was performed for a subsample of participants with at least 1 of the chronic diseases used in the quality of care (QOC) measure ( 74 intervention and 78 control patients). INTERVENTIONS At-risk patients were randomly assigned to receive usual care from their family physicians or APTCare from a collaborative team. MAIN OUTCOME MEASURES Cost-effectiveness and the net benefit to society of the APTCare intervention. RESULTS Costs not directly associated with delivery of the intervention were similar in the 2 arms: $9121 and $9222 for the APTCare and control arms, respectively. Costs directly associated with the program were $3802 per patient for a total cost per patient of $12 923 and $9222, respectively (P=.033). A 1% improvement in QOC was estimated to cost $407 per patient. Analysis of the net benefit to society in absolute dollars found a break-even threshold of $750 when statistical significance was required. This implies that society must place a value of at least $750 on a 1% improvement in QOC in order for the intervention to be socially worthwhile. By any of the metrics used, the APTCare intervention was not cost-effective, at least not in a population for which baseline QOC was high. CONCLUSION Although our calculations suggest that the APTCare intervention was not cost-effective, our results need the following caveats. The costs of such a newly introduced intervention are bound to be higher than those for an established, up-and-running program. Furthermore, it is possible that some benefits of the secondary preventive measures were not captured in this limited 12- to 18-month study or were simply not measured.
引用
收藏
页码:E20 / E29
页数:10
相关论文
共 50 条
  • [21] Multidisciplinary outpatient care program for patients with chronic low back pain: design of a randomized controlled trial and cost-effectiveness study [ISRCTN28478651]
    Ludeke C Lambeek
    Johannes R Anema
    Barend J van Royen
    Peter C Buijs
    Paul I Wuisman
    Maurits W van Tulder
    Willem van Mechelen
    BMC Public Health, 7
  • [22] Multidisciplinary outpatient care program for patients with chronic low back pain: design of a randomized controlled trial and cost-effectiveness study [ISRCTN28478651]
    Lambeek, Ludeke C.
    Anema, Johannes R.
    van Royen, Barend J.
    Buijs, Peter C.
    Wuisman, Paul I.
    van Tulder, Maurits W.
    van Mechelen, Willem
    BMC PUBLIC HEALTH, 2007, 7 (1)
  • [23] Cost-effectiveness of multidisciplinary collaborative care versus usual care in the management of high-risk patients with diabetes in Singapore: Short-term results from a randomized controlled trial
    Siaw, M. Y. L.
    Malone, D. C.
    Ko, Y.
    Lee, J. Y. -C.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2018, 43 (06) : 775 - 783
  • [24] Cost-effectiveness of eletriptan versus zolmitriptan: Results from a randomized controlled trial
    Mullins, CD
    Healey, PJ
    Mychaskiw, M
    Meng, F
    Weis, KA
    VALUE IN HEALTH, 2005, 8 (03) : 318 - 318
  • [25] Cost-effectiveness of eletriptan versus sumatriptan: Results from a randomized, controlled trial
    Weis, K
    Perfetto, E
    Mullins, CD
    Healey, P
    Subedi, P
    Meng, F
    VALUE IN HEALTH, 2006, 9 (03) : A83 - A83
  • [26] Cost-effectiveness of multidisciplinary wound care in nursing homes: a pseudo-randomized pragmatic cluster trial
    Vu, Trang
    Harris, Anthony
    Duncan, Gregg
    Sussman, Geoff
    FAMILY PRACTICE, 2007, 24 (04) : 372 - 379
  • [27] Cost-Effectiveness of Caries Prevention in Practice: A Randomized Controlled Trial
    O'Neill, C.
    Worthington, H. V.
    Donaldson, M.
    Birch, S.
    Noble, S.
    Killough, S.
    Murphy, L.
    Greer, M.
    Brodison, J.
    Verghis, R.
    Tickle, M.
    JOURNAL OF DENTAL RESEARCH, 2017, 96 (08) : 875 - 880
  • [28] Cost-effectiveness of online positive psychology: Randomized controlled trial
    Bolier, Linda
    Majo, Cristina
    Smit, Filip
    Westerhof, Gerben J.
    Haverman, Merel
    Walburg, Jan A.
    Riper, Heleen
    Bohlmeijer, Ernst
    JOURNAL OF POSITIVE PSYCHOLOGY, 2014, 9 (05): : 460 - 471
  • [29] Cost-Effectiveness of Initiating Dialysis Early: A Randomized Controlled Trial
    Harris, Anthony
    Cooper, Bruce A.
    Li, Jing Jing
    Bulfone, Liliana
    Branley, Pauline
    Collins, John F.
    Craig, Jonathan C.
    Fraenkel, Margaret B.
    Johnson, David W.
    Kesselhut, Joan
    Luxton, Grant
    Pilmore, Andrew
    Rosevear, Martin
    Tiller, David J.
    Pollock, Carol A.
    Harris, David C.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (05) : 707 - 715
  • [30] Cost-effectiveness of primary titanium cranioplasty: A randomized controlled trial
    Honeybul, Stephen
    Morrison, David
    Ho, Kwok
    Lind, Christopher
    Geelhoed, Elizabeth
    BRAIN INJURY, 2016, 30 (5-6) : 498 - 498